Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 165 results
Author Title [ Year(Desc)]
Filters: Author is Aplenc, Richard  [Clear All Filters]
Arnold SD, Brazauskas R, He N, et al. "Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases." Haematologica. 2017;102(11):1823-1832.
Winestone LE, Getz KD, Miller TP, et al. "Complications preceding early deaths in Black and White children with acute myeloid leukemia." Pediatr Blood Cancer. 2017.
Citrin R, Horowitz JP, Reilly AF, et al. "Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database." PLoS ONE. 2017;12(10):e0186960.
Vujkovic M, Bellamy SL, Zuppa AF, et al. "CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV-Infected Patients in Botswana." J. Acquir. Immune Defic. Syndr.. 2017.
Gross R, Bellamy SL, Ratshaa B, et al. "CYP2B6 genotypes and early efavirenz-based hiv treatment outcomes in botswana." AIDS. 2017.
Tarlock K, Alonzo TA, Loken MR, et al. "Disease Characteristics and Prognostic Implications of Cell Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group." Clin. Cancer Res.. 2017.
Guest EM, Aplenc R, Sung L, et al. "Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials, AAML03P1 and AAML0531." Blood. 2017.
Vujkovic M, Attiyeh EF, Ries RE, et al. "Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report." Blood. 2017;129(23):3051-8.
Glisovic-Aplenc T, Gill S, Spruce LA, et al. "Improved plasma membrane proteome coverage with a label-free non-affinity-purified workflow." Proteomics. 2017.
Lim EL, Trinh DL, Ries RE, et al. "MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia." J. Clin. Oncol.. 2017:JCO2017747451.
Hanley MJ, Mould DR, Taylor TJ, et al. "Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range." J Clin Pharmacol. 2017.
Miller TP, Li Y, Getz KD, et al. "Using electronic medical record data to report laboratory adverse events." Br. J. Haematol.. 2017.
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Li Y, Newton JG, Getz KD, et al. "Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia." Pediatr Blood Cancer. 2018:e27583.
DiNofia AM, Seif AE, Devidas M, et al. "Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232." Cancer Med. 2018;7(1):3-12.
Citrin R, Getz KD, Li Y, et al. "The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma." Br. J. Haematol.. 2018.
Fitzgerald JC, Li Y, Fisher BT, et al. "Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia." Pediatr Crit Care Med. 2018;19(6):e312-20.
Elgarten CW, Arnold SD, Li Y, et al. "Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation." Infect Control Hosp Epidemiol. 2018:1-9.
Szymczak JE, Getz KD, Madding R, et al. "Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia." Pediatr Blood Cancer. 2018;65(4).
Burstein DS, Li Y, Getz KD, et al. "Mortality, Resource Utilization And Inpatient Costs Vary Among Pediatric Heart Transplant Indications: A Merged Data Set Analysis From The United Network For Organ Sharing And The Pediatric Health Information Systems (UNOS-PHIS) Databases." J. Card. Fail.. 2018.
Getz KD, Sung L, Ky B, et al. "Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group." J. Clin. Oncol.. 2018:JCO1800313.
Getz KD, Miller TP, Seif AE, et al. "Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia." PLoS ONE. 2018;13(2):e0192529.
Scheurer ME, Lupo PJ, Schüz J, et al. "An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016." Pediatr Hematol Oncol. 2018:1-16.
Vujkovic M, Bellamy SL, Zuppa AF, et al. "Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana." Pharmacogenomics J.. 2018.
Bride KL, Vincent TL, Im S-Y, et al. "Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia (T-ALL)." Blood. 2018;131(9):995-9.